Spaces plans to open a new location in Houston this month, Chevron Technology Ventures invests in autonomous vehicle tech, and more Houston innovation news. Courtesy of Spaces

A lot is happening in the Houston innovation ecosystem — so much that you may have missed a few key news items. Let's hit the highlights, shall we?

Applications are open for major health tech awards program that is coming to town, a Houston corporate venture fund doles out cash to self-driving cars, new coworking space to deliver, a diversity-focused partnership launches, and more Houston innovation news.

Chevron Technology Ventures invests in self-driving cars

Voyage is growing its fleet of self-driving vehicles with the help of a Houston corporate VC fund. Photo via voyage.auto

Silicon Valley's Voyage, a self-driving car technology company, closed its series B round at $31 million. Houston-based Chevron Technology Ventures contributed to the round.

The round's funds will go toward expanding the company's fleet of G2 autonomous vehicles in California and Florida, as well as introduce Voyage's G3 self-driving car, Oliver Cameron, co-founder and CEO at Voyage, writes in a release.

"Chevron has been supporting the public's transportation needs for over 100 years. As our customers' mobility needs and preferences change, we want to continue to be part of their journeys. Our investment in Voyage affirms this commitment," says Barbara Burger, CTV president, in a release. "We established the Future Energy Fund in 2018 with an initial commitment of $100 million to invest in breakthrough technologies that enable the ongoing energy transition. The fund looks for technologies that lower emissions and support low carbon value chains. Our investment in Voyage fits well within the objectives of the Future Energy Fund while also informing our perspective on the changing energy landscape."

Accenture to close out health tech challenge in Houston

accenture

The national challenge will conclude in Houston. Courtesy of Accenture

Applications are open for the fourth annual Accenture HealthTech Innovation Challenge and close on September 22. Finalists will present to judges from global health companies at one of two regional events — in Boston on Nov. 7 or in San Francisco on Dec. 5. The final judging event will take place in Houston on February 6, 2020.

"We look forward to this year's submissions as we continue to identify bold ideas from startups that deliver new solutions for health organizations to improve the lives of consumers, clinicians and employees," says Brian Kalis, managing director of digital health and innovation at Accenture, in a release. "Since its inception, the Accenture HealthTech Innovation Challenge has brought healthcare organizations and startups together to tackle the world's biggest health issues where we have received more than 2,200 applications, invited more than 90 startups to compete and who have benefitted from the guidance of nearly 1,000 executive judges from the healthcare industry."

The submission form, including additional details about the challenge's criteria, eligibility, and requirements, is available at: Accenture HealthTech Innovation Challenge-Health.

GotSpot wins pitch competition

Reda Hicks claimed the win at a military spouse pitch event. Trish Alegre-Smith/Military.com

Reda Hicks, who founded Houston-based GotSpot Inc., won a $15,000 check from the StreetShares Foundation and Samuel Adams' Brewing the American Dream at the Great American Military Entrepreneur at the Military Influencer Conference in Washington, D.C.

GotSpot is a website that allows for people with commercial space — a commercial kitchen, conference room, spare desks, etc. — to list it. Then, space seekers — entrepreneurs, nonprofits, freelancers, etc. — can rent it.

"This award is a game-changer for me," Hicks says to Military.com. "This will allow me to hire more incredible military spouses and help GotSpot on its path to go global."

Rice University launches new sports business course

Rice University

Rice University has a new sports business program. Photo courtesy of Rice University

Rice University, along with the Houston Texans, is introducing a new program for the university's sport management students. Pro Sports: Management is a course designed to teach the business side of the sports world.

"We are thrilled to partner with Rice University on a curriculum that will provide their best and brightest students with insight into the real-world opportunities and challenges facing today's sports teams," says Houston Texans President Jamey Rootes in a release from Rice. "This program is rather unique because our leading executives will work alongside Rice professors to teach current best practices in franchise management across every discipline. We believe that this type of practical industry exposure is the best way to prepare the next generation of leaders in the field of sports management and a valuable contribution to the level of professionalism within our industry."

The classes will be held weekly in the executive offices of the Texans. The course will cover ticketing, public relations, event management, human resources and more.

Spaces plans to open second coworking location in Houston

Spaces, an Amsterdam-based coworking space company that entered the Houston market with a lease in Kirby Grove announced in 2017, plans to open its newest location this month. Courtesy of Spaces

The new Spaces CityCentre One location is planned to open on Monday, September 30. It's the Amsterdam-based company's second coworking space in Houston, with a third already in the works. The first location was in Kirby Grove in 2017, and Spaces Galleria at Post Oak will be opening in the second quarter of 2020.

The CityCentre One location will have over 60,000 square-feet of workspace with perks, including a business club, dedicated desk space, private offices, and seven fully-equipped meeting rooms. Plus, the building is just steps away from CityCentre, a mixed-use development with restaurants, entertainment, housing, and more. Membership pricing starts at $111 a month at the new location.

Cemvita Factory receives more backing from oil and gas industry

Cemvita FactoryCemvita Factory

Houston-based Cemvita Factory, a biotech company that can mimick photosynthesis and convert CO2 into glucose and other substances, has received equity investment from BHP. The amount of the investment was not disclosed.

The investment will help Cemvita Factory continue to develop its biomimicry technology for oil and gas applications to reduce the volume of greenhouse gas emissions.

"This strategic investment fits well with BHP's vision of the future: reducing operational greenhouse gas emissions, reducing environmental impact and the development of low-emissions technology, including increased application of carbon capture, utilization and storage technology," says BHP's chief geoscientist, Laura Tyler, in a release.

Last month, Occidental Petroleum's low carbon subsidiary, Oxy Low Carbon Ventures LLC, announced it invested an undisclosed amount of funds into Cemvita Factory.

Two organizations join forces to promote diversity in the Houston Startup Scene

Impact Hub Houston and The Cannon have teamed up to grow programming and events surrounding diversity. Photo courtesy of The Cannon

In an effort to promote diversity and inclusion within the Houston innovation ecosystem, The Cannon and Impact Hub Houston have teamed up. The collaboration will drive programming and events geared at growing the conversation and resources for startups and entrepreneurs.

"One of Houston's best differentiating qualities is that we are truly a melting pot," says Lawson Gow, founder and CEO of The Cannon, in a news release. "We want our community to reflect the amazing diversity across our city, so we have to move beyond simply discussing diversity and work to create an environment where innovation can thrive and real change can happen. We are confident Impact Hub will be the perfect partner to bring those aspects to our community."

Gow, who is the son of InnovationMap's parent company's CEO, opened the doors to its new 120,000-square-foot facility in July. Impact Hub Houston will have a presence in the space.

"Over the past few years, Lawson and I have brainstormed how we could work together to connect and grow our region's innovation ecosystem and demonstrate how organizations can evolve from competition to true collaboration," says Grace Rodriguez, CEO and Executive Director of Impact Hub Houston, in the release. "I'm so excited that those talks have developed into this partnership: Through The Cannon and Impact Hub Houston, we'll be able to effectively 'meet people where they are' geographically, socially, and culturally, helping diverse entrepreneurs and startups at the myriad intersections of place, purpose, demographics, psychographics, and business growth stages."

Houston innovator nominated for prestigious Silicon Valley award

Alley Lyles is up for an award for her work in digital transformation.

Alley Lyles, digital transformation manager at Direct Energy and Houston startup mentor, was nominated for a Women in IT - Silicon Valley award as Transformation Leader of the Year. The awards event is on October 9.

She is up against Emily Dunn at Anaplan, Windy Garrett at Atos, Manju Abraham at Delphix, Aashima Gupta at Google, Patricia Grant at ServiceNow, and Nataliya Anon at Svitla Systems.

"I am proud to represent Houston in Silicon Valley. The Houston hustle is real. I see it amongst my colleagues who got me here. The hustle isn't always glamorous, so I appreciate the moment when a kid from the East End can shine."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”

10+ Houston innovation leaders in the spotlight at SXSW 2026

where to be

Houston's innovation scene will be well represented at South by Southwest (SXSW) this month.

The week-long, Austin-based conference and festival will spotlight some of the Bayou City's leaders in health care, energy, space and more. The event kicks off today, March 12, and runs through March 18. The SXSW Innovation Conference will feature keynotes, workshops, mentoring sessions and more throughout various venues in the city.

Here's who to see and when and where to find them:

March 12

Aileen Allen, venture partner at Mercury Fund

Mentor Session from 4-5:15 p.m. at Hilton Austin Downtown

Allen will host a mentoring session focused on funding, marketing, advertising, PR and the future of work.

March 13

Heath Butler, partner at Mercury Fund

SXSW Pitch-Smart Cities, Transportation, Manufacturing & Logistics from 2:30-3:30 p.m. at the J.W. Marriott

Butler will judge five innovative startups as they pitch their solutions to advance smart cities, enhance transportation systems, modernize manufacturing, transform logistics, and strengthen government infrastructure and civic operations.

Jonathan Cirtain, CEO and president of Axiom Space

The Clock is Ticking for Space - Replacing the ISS from 4-5 p.m. at the J.W. Marriott

Cirtain will discuss Axiom's pursuit of building the world’s first commercial space station.

March 14

Jesse Martinez, founder and CEO of LSA Global

SXSW Pitch-Intelligent Systems, Robotics, & Multisensory Technology from 10-11 a.m. at the J.W. Marriott

Martinez will judge five innovative startups as they pitch their technologies that aim to enhance the way people connect, communicate and share unique life experiences with those around them in a digital ecosystem.

Jennifer Schmitt, head of operations at Rhythm Energy

Powering Texas with Reliable Integrated High-Demand Energy from 10-11 a.m. at Marlow

Schmitt will join a panel to discuss how EirGrid, the state-owned electric power transmission operator in Ireland, is pioneering solutions as the country works toward 80 percent renewable integration by 2030.

Saki Sasagawa, director of business development for JETRO Houston

Now is Japan's Time: Leading the Future with Deep Tech from 10-11 a.m. at the J.W. Marriott

Sasagawa joins a panel that will share real-time insights from diverse perspectives on the forefront of Japan’s deep tech and IP businesses.

March 15

Bosco Lai, CEO and co-founder of Little Place Labs

SXSW Pitch Alumni: Where Are They Now? from 10-11 a.m. at the J.W. Marriott

Lai joins a panel of four former SXSW Pitch winners to share how they leveraged the platform to take their startups to the next level.

Tara Karimi, cofounder and chief science and sustainability officer at Cemvita

South by South America: The Rise of Southern Brazil Tech from 2:30-3:30. p.m. at The Line

Karimi will participate in a panel to discuss how Rio Grande do Sul, Brazil's southernmost state, is attracting elite talent and AI infrastructure and share insights on navigating the next wave of South American tech growth.

March 16

Dr. Pavitra P. Krishnamani, emergency medicine physician at The University of Texas MD Anderson Cancer Center

Viva La Revolution: How the Digital Age is Transforming Wellness from 11:30 a.m.-12:30 p.m. at Hilton Austin Downtown

Krishnamani will discuss the latest advancements and policies that can accelerate the digital age of health care, such as wearables, telehealth and artificial intelligence.

March 18

Charlie Childs, co-founder and CEO of Intero Biosystems

Spinning Out: What It Takes to Build a University Startup from 2:30-3:30 p.m. at The Line

Childs will join founders who spun their companies out of the University of Michigan to share the real story of navigating IP, early capital, team building, market validation and the “valley of death.”

Dr. James Allison, regental chair of immunology and director of The Allison Institute at The University of Texas MD Anderson Cancer Center

Dr. Padmanee Sharma, professor in the Department of Genitourinary Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center

Beyond Checkpoints: Immunotherapy’s Next Act from 2:30-3:30 p.m. at the J.W. Marriott

Allison and Sharma will sit down with 21-year-old, Stage 4 cancer survivor Sharon Belvin and Time Magazine journalist Alice Park will discuss the future of immunotherapy and what challenges remain.

Last year, Houston startups Little Places Labs and Helix Earth won top prizes in their respective categories at the prestigious SXSW Pitch event, held this year from March 13-14. No Houston startups were named finalists to compete in this year's event.

NASA revamps Artemis moon landing program by modeling it after Apollo

To the moon

NASA is revamping its Artemis moon exploration program to make it more like the fast-paced Apollo program half a century ago, adding an extra practice flight before attempting a high-risk lunar landing with a crew in two years.

The overhaul in the flight lineup came just days after NASA’s new moon rocket returned to its hangar for more repairs, and a safety panel warned the space agency to scale back its overly ambitious goals for humanity’s first lunar landing since 1972.

Artemis II, a lunar fly-around by four astronauts, is off until at least April because of rocket problems.

The follow-up mission, Artemis III, had been targeting a landing near the moon’s south pole by another pair of astronauts in about three years. But with long gaps between flights and concern growing over the readiness of a lunar lander and moonwalking suits, NASA’s new administrator Jared Isaacman announced that mission would instead focus on launching a lunar lander into orbit around Earth in 2027 for docking practice by astronauts flying in an Orion capsule.

The new plan calls for a moon landing — potentially even two moon landings — by astronauts in 2028.

“Everybody agrees. This is the only way forward,” Isaacman said.

The hydrogen fuel leaks and helium flow problems that struck the Space Launch System rocket on the pad at NASA's Kennedy Space Center in February also plagued the first Artemis test flight without a crew in 2022.

Another three-year gap was looming between Artemis II and the moon landing by astronauts as originally envisioned, Isaacman said.

Isaacman stressed that “it should be incredibly obvious” that three years between flights is unacceptable. He'd like to get it down to one year or even less.

Isaacman, a tech billionaire who bought his own trips to orbit and performed the world’s first private spacewalk, took the helm at NASA in December.

During NASA’s storied Apollo program, he said, astronauts’ first flight to the moon was followed by two more missions before Neil Armstrong and Buzz Aldrin landed on the moon. What's more, he added, the Apollo moonshots followed one another in quick succession, just as the earlier Projects Mercury and Gemini had rapid flight rates, sometimes coming just a few months apart.

Twenty-four Apollo astronauts flew to the moon from 1968 through 1972, with 12 of them landing.

“No one at NASA forgot their history books. They knew how to do this," Isaacman said. “Now we're putting it in action.”

To pick up the pace and reduce risk, NASA will standardize its Space Launch System rockets moving forward, Isaacman said. These are the massive rockets that will launch astronauts to the moon aboard Orion capsules. At the same time, Elon Musk's SpaceX and Jeff Bezos' Blue Origin are speeding up their work on the landers needed to get the astronauts from lunar orbit down to the surface.

Isaacman said next year will see an Orion crew rendezvousing in orbit around Earth with SpaceX's Starship, Blue Origin's Blue Moon or both landers. It's similar to the methodical approach that worked so well during Apollo in the late 1960s, he noted. Apollo 8, astronauts' first flight to the moon, was followed by two more missions before Armstrong and Aldrin aimed for the lunar surface.

“We should be getting back to basics and doing what we know works,” he said.

The Aerospace Safety Advisory Panel recommended that NASA revise its objectives for Artemis III “given the demanding mission goals.” It’s urgent the space agency do that, the panel said, if the United States hopes to safely return astronauts to the moon. Isaacman said the revised Artemis flight plan addresses the panel's concerns and is supported by industry and the Trump administration.